Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SELECT-A: TS stratified Chemotherapy and VEGF Inhibition in Non-Squamous Non-Small Cell Lung Cancer - Stage IV
2011-002145-35Phase 2Terminated
- Sponsor
- Aktion Bronchialkarzinom
- Start
- Jul 2012
- Modality
- Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab, pemetrexed, cisplatin in Non-small cell lung cancer (NS-NSCLC), sponsored by Aktion Bronchialkarzinom. Started Jul 2012; status: terminated.
02
Drugs
bevacizumabpemetrexedcisplatin
03
Conditions
Non-small cell lung cancer (NS-NSCLC)
Beyond the preview
Go deeper on 2011-002145-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002145-35.